Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
2 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
L1077P CFTR pathogenic variant function rescue by Elexacaftor-Tezacaftor-Ivacaftor in cystic fibrosis patient-derived air-liquid interface (ALI) cultures and organoids: in vitro guided personalized therapy of non-F508del patients.
Respir Res. 2023 Sep 6;24(1):217. doi: 10.1186/s12931-023-02516-0.
Respir Res. 2023.
PMID: 37674160
Free PMC article.
Correction to: L1077P CFTR pathogenic variant function rescue by Elexacaftor-Tezacaftor-Ivacaftor in cystic fbrosis patient-derived air-liquid interface (ALI) cultures and organoids: in vitro guided personalized therapy of non-F508del patients.
Lo Cicero S, Castelli G, Blaconà G, Bruno SM, Sette G, Pigliucci R, Villella VR, Esposito S, Zollo I, Spadaro F, De Maria R, Biffoni M, Cimino G, Amato F, Lucarelli M, Eramo A.
Lo Cicero S, et al. Among authors: pigliucci r.
Respir Res. 2023 Sep 23;24(1):228. doi: 10.1186/s12931-023-02535-x.
Respir Res. 2023.
PMID: 37742000
Free PMC article.
No abstract available.
Item in Clipboard
Cite
Cite